These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30531253)

  • 21. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    Stone GW; Sabik JF; Serruys PW; Simonton CA; Généreux P; Puskas J; Kandzari DE; Morice MC; Lembo N; Brown WM; Taggart DP; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman P; Bochenek A; Schampaert E; Pagé P; Dressler O; Kosmidou I; Mehran R; Pocock SJ; Kappetein AP;
    N Engl J Med; 2016 Dec; 375(23):2223-2235. PubMed ID: 27797291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.
    Huang X; Redfors B; Chen S; Liu Y; Ben-Yehuda O; Puskas JD; Kandzari DE; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Sabik JF; Serruys PW; Kappetein AP; Stone GW
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1144-1151. PubMed ID: 30596978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
    Kosmidou I; Redfors B; Chen S; Crowley A; Lembo NJ; Karmpaliotis D; Brown WM; Maupas E; Durrleman N; Shah A; Reardon MJ; Dressler O; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Am Heart J; 2019 Apr; 210():49-57. PubMed ID: 30738244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes following surgical revascularization with single versus bilateral internal thoracic arterial grafts in patients with left main coronary artery disease undergoing coronary artery bypass grafting: insights from the EXCEL trial†.
    Thuijs DJFM; Head SJ; Stone GW; Puskas JD; Taggart DP; Serruys PW; Dressler O; Crowley A; Brown WM; Horkay F; Boonstra PW; Bogáts G; Noiseux N; Sabik JF; Kappetein AP
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):501-510. PubMed ID: 30165487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient Versus Inpatient Percutaneous Coronary Intervention in Patients With Left Main Disease (from the EXCEL Trial).
    Gaba P; Serruys PW; Karmpaliotis D; Lembo NJ; Banning AP; Zhang Z; Morice MC; Kandzari DE; Gershlick AH; Ben-Yehuda O; Sabik JF; Kappetein AP; Stone GW
    Am J Cardiol; 2021 Mar; 143():21-28. PubMed ID: 33359193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.
    Park DW; Ahn JM; Yun SC; Yoon YH; Kang DY; Lee PH; Lee SW; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Park SJ
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2813-2822. PubMed ID: 30261236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery disease.
    Chen S; Redfors B; Serruys PW; Pieter Kappetein A; Crowley A; Ben-Yehuda O; Srdanovic I; Lembo NJ; Brown WM; Sabik JF; Stone GW
    Coron Artery Dis; 2022 Jan; 31(1):37-44. PubMed ID: 34010183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
    Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
    Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    Stone GW; Kappetein AP; Sabik JF; Pocock SJ; Morice MC; Puskas J; Kandzari DE; Karmpaliotis D; Brown WM; Lembo NJ; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman PE; Bochenek A; Schampaert E; Pagé P; Modolo R; Gregson J; Simonton CA; Mehran R; Kosmidou I; Généreux P; Crowley A; Dressler O; Serruys PW;
    N Engl J Med; 2019 Nov; 381(19):1820-1830. PubMed ID: 31562798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Coronary Artery Bypass Graft Surgery Versus Drug-Eluting Stents in Older Adults.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    J Am Geriatr Soc; 2017 Mar; 65(3):625-630. PubMed ID: 28165613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.